A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2011
12/08/2011	WO2011151386A1 Process for making dry and stable hemostatic compositions
12/08/2011	WO2011151384A1 Process for making dry and stable hemostatic compositions
12/08/2011	WO2011151087A1 Oral dosage forms of bendamustine
12/08/2011	WO2011151086A1 Oral dosage forms of bendamustine and therapeutic use thereof
12/08/2011	WO2011151080A1 Pharmaceutical compositions of co-crystals of tramadol and coxibs
12/08/2011	WO2011151018A2 Orodispersible tablets of erythritol and isomalt
12/08/2011	WO2011150960A1 Formulation comprising nicotine and a cation exchange resin
12/08/2011	WO2011150959A1 Formulation comprising nicotine and a cation exchange resin
12/08/2011	WO2011150944A1 Trefoil factors (tff) for the treatment of chronic pulmonary diseases
12/08/2011	WO2011150859A1 Oral meclizine aqueous formulations with taste flavoring agent
12/08/2011	WO2011150506A1 Multi phase soft gel capsules, apparatus and method thereof
12/08/2011	WO2011150505A1 Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation
12/08/2011	WO2011150481A1 Nanoparticulate composition containing antibiotics for intramammary administration in animals
12/08/2011	WO2011150441A1 Medical aerosol formulation comprising ribavirin
12/08/2011	WO2011128910A3 A drug delivery solid dosage formulation of sirolimus
12/08/2011	WO2011115599A3 Orally disintegrating tablet formulations of donepezil and process for preparing the same
12/08/2011	WO2011110662A8 Supported biologically active compounds
12/08/2011	WO2011100460A3 Ccr7 ligand delivery and co-delivery in immunotherapy
12/08/2011	WO2011051155A3 Stable protective coatings for pharmaceutical dosage forms
12/08/2011	WO2011042902A3 Microcapsules comprising benzoyl peroxide and topical compositions comprising them
12/08/2011	WO2011015744A3 Injectable composition combining a filling agent and a fibroblast growth medium
12/08/2011	WO2011012912A3 New granulating process and thus prepared granulate
12/08/2011	WO2011008923A3 Olopatadine nasal spray regimen for children
12/08/2011	WO2010120389A8 Polymeric drug delivery systems and processes for producing such systems
12/08/2011	WO2010102148A3 An improved dry powder drug delivery system
12/08/2011	US20110301525 Biomaterials for tissue replacement
12/08/2011	US20110301452 Microcapsule for local treatment of a tumor and method for positioning a magnetic gradient field guiding magnetic nanoparticles to a target location as well as apparatus for positioning a magnetic gradient field
12/08/2011	US20110301248 Compositions and methods of delivery of pharmacological agents
12/08/2011	US20110301231 Lipase inhibiting composition
12/08/2011	US20110301213 Use of pilocarpine for hypoptyalism treatment
12/08/2011	US20110301129 Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
12/08/2011	US20110301100 Pharmaceutical Compositions Comprising Polyethylene Glycol Having a Molecular Weight of Less Than 600 Daltons
12/08/2011	US20110301097 Oral Administration Of Therapeutic Agent Coupled To Transporting Agent
12/08/2011	US20110300226 Peptide particle formulation
12/08/2011	US20110300225 Nutritional compositions with coated lipid globules
12/08/2011	US20110300224 Taste masked dosage form of pharmaceutically acceptable salt of escitalopram
12/08/2011	US20110300223 Immunogenic composition
12/08/2011	US20110300222 Luminescent porous silicon nanoparticles, methods of making and using same
12/08/2011	US20110300221 Therapeutic Inhibitor of Vascular Smooth Muscle Cells
12/08/2011	US20110300220 Solid calcium lactate in substantially spherical form
12/08/2011	US20110300219 Nanostructures for drug delivery
12/08/2011	US20110300218 Novel solid state forms of ranolazine salts
12/08/2011	US20110300217 Hydromorphone therapy
12/08/2011	US20110300216 Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives
12/08/2011	US20110300215 Tablet formulation of ezatiostat
12/08/2011	US20110300214 Pharmaceutical compositions comprising 5-chloro-n-(-methyl)-2-thiophencarboxamid
12/08/2011	US20110300213 Oral formulations of bipolar trans carotenoids
12/08/2011	US20110300212 Pharmaceutical Formulation
12/08/2011	US20110300211 Soft-gelatin capsule formulation
12/08/2011	US20110300210 Controlled release nanoparticulate clozapine compositions
12/08/2011	US20110300209 Modified release solid pharmaceutical compositions of trimetazidine and process thereof
12/08/2011	US20110300208 Segmented pharmaceutical dosage forms
12/08/2011	US20110300207 Method of treating post-surgical acute pain
12/08/2011	US20110300206 Vaccines against chlamydial infection
12/08/2011	US20110300205 Self replicating rna molecules and uses thereof
12/08/2011	US20110300204 Nutritional compositions with large lipid globule size
12/08/2011	US20110300203 Cartilage regeneration without cell transplantation
12/08/2011	US20110300202 Medical item for long term durg release
12/08/2011	US20110300199 Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions
12/08/2011	US20110300198 Hydrocolloid - essential oil patches
12/08/2011	US20110300195 Ophthalmic Compositions Comprising Calcineurin Inhibitors or mTOR Inhibitors
12/08/2011	US20110300194 Flexible Bone Composite
12/08/2011	US20110300193 Ambient stored blood plasma expanders
12/08/2011	US20110300192 Magnesium oxide granules
12/08/2011	US20110300191 Multiple-layer immune barrier for donor cells
12/08/2011	US20110300190 Compound, composition and uses thereof
12/08/2011	US20110300189 Antimicrobial colloidal silver products and method of making same
12/08/2011	US20110300188 Glassy calcium phosphate particulates, coatings and related bone graft materials
12/08/2011	US20110300187 Antioxidant camptothecin derivatives and antioxidant antineoplastic nanospheres thereof
12/08/2011	US20110300186 Functionalized Nano- and Micro-materials for Medical Therapies
12/08/2011	US20110300185 Immunogenic escherichia coli heat stable enterotoxin
12/08/2011	US20110300184 Pharmaceutical compositions for treating or preventing bone conditions
12/08/2011	US20110300081 Orosoluble and/or effervescent compositions containing at least a salt of s-adenosyl methionine (same)
12/08/2011	US20110300078 Isolation of microbubbles of selected size range from polydisperse microbubbles
12/08/2011	US20110297755 Prefilming atomizer
12/08/2011	DE102010022926A1 Mikrokapsel zur lokalen Behandlung eines Tumors, Verfahren zur Positionierung eines magnetische Nanopartikel an einen Zielort führenden und/oder an dem Zielort haltenden magnetischen Gradientenfeldes und Vorrichtung zur Positionierung eines magnetischen Gradientenfeldes Microcapsule for the local treatment of a tumor, method for positioning a magnetic nanoparticles leading to a destination and / or holding at the target location and magnetic gradient field apparatus for positioning a magnetic gradient field
12/08/2011	CA2801645A1 Methods of treatment of pancreatic cancer
12/08/2011	CA2801585A1 Peptide particle formulation
12/08/2011	CA2801554A1 Nasal immunization
12/08/2011	CA2801535A1 Composition and method for inner ear sensory hair cell regeneration or replacement
12/08/2011	CA2801314A1 Methods of treating bladder cancer
12/08/2011	CA2801309A1 Methods and compositions for oral pharmaceutical therapy
12/08/2011	CA2801266A1 Oral vaccine comprising an antigen and a toll-like receptor agonist
12/08/2011	CA2801120A1 Process for making dry and stable hemostatic compositions
12/08/2011	CA2801118A1 Process for making dry and stable hemostatic compositions
12/08/2011	CA2801116A1 Process for making dry and stable hemostatic compositions
12/08/2011	CA2800401A1 Biodegradable lipids for the delivery of active agents
12/08/2011	CA2800279A1 Oral dosage forms of bendamustine
12/08/2011	CA2800277A1 Oral dosage forms of bendamustine and therapeutic use thereof
12/08/2011	CA2800266A1 Orodispersible tablets of erythritol and isomalt
12/08/2011	CA2798090A1 Pharmaceutical compositions of co-crystals of tramadol and coxibs
12/08/2011	CA2796620A1 Injectable formulation
12/07/2011	EP2392559A1 Therapeutic compounds
12/07/2011	EP2392378A1 Microneedle device
12/07/2011	EP2392354A1 Finely pulverized pharmaceutical composition
12/07/2011	EP2392353A1 Anti A beta antibody formulation
12/07/2011	EP2392341A1 Compositions for use in treating myelodysplastic syndrome
12/07/2011	EP2392330A1 Compositions for use in treating myelodysplastic syndrome
12/07/2011	EP2392329A1 Compositions for use in treating myelodysplastic syndrome
12/07/2011	EP2392321A1 Combined composition for rectal administration for the treatment of inflammatory bowel disease

1 ... 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 ... 2991